Diagnostic Underuse and Antimicrobial Resistance Patterns Among Hospitalized Children in a National Referral Hospital

Veronicah M Chuchu1,2,3,4,5, Teresa Ita2, Irene Inwani6,7

  • 1Department of Medical Microbiology, University of Nairobi, Nairobi P.O. Box 19676-00202, Kenya.

PubMed

Insights

Limited diagnostic use and high rates of multidrug-resistant organisms (MDROs) and extensively drug-resistant (XDR) infections were found in Kenyan children. Enhancing pediatric diagnostics and antimicrobial stewardship is crucial.

Area of Science:

  • Infectious Diseases
  • Global Health
  • Pediatric Medicine
  • Antimicrobial Resistance

Background:

  • Antimicrobial resistance (AMR) poses a significant global health challenge, disproportionately affecting children in low- and middle-income countries.
  • Limited data exist on AMR patterns and diagnostic practices within pediatric populations in these regions.
  • This study addresses the need for data on diagnostic utilization and AMR in hospitalized children in Kenya.

Purpose of the Study:

  • To evaluate diagnostic utilization among pediatric inpatients with bacterial infections.
  • To determine the prevalence of antimicrobial resistance, including multidrug-resistant organisms (MDROs) and extensively drug-resistant (XDR) infections, in this population.
  • To identify risk factors associated with MDRO infections in hospitalized children.

Main Methods:

  • A retrospective cohort study was conducted on pediatric inpatients (0-12 years) admitted with bacterial infections from 2017 to 2021.
  • Patient records were reviewed for diagnostic testing (cultures, antimicrobial susceptibility testing) and infection data.
  • Descriptive statistics and logistic regression were used to analyze infection counts, diagnostic utilization, resistance outcomes, and associated risk factors.

Main Results:

  • Of 1608 patients, 63% were infants under one year. Diagnostic cultures were performed in 40% and susceptibility testing in only 17% of cultured samples.
  • The most common infection was gastroenteritis (46%). Among isolated organisms, Klebsiella pneumoniae showed 100% resistance to third-generation cephalosporins.
  • High rates of MDROs (72% of tested samples, 76% of tested patients) and XDR infections (28% of MDRO samples, 30% of MDRO patients) were observed. Children under 5 and those with multiple admissions had higher odds of MDRO infections.

Conclusions:

  • The study highlights significantly limited diagnostic utilization and a high burden of MDROs and XDR infections among hospitalized children in Kenya.
  • Younger age and multiple hospital admissions are associated with increased risk of MDRO infections.
  • Urgent strengthening of diagnostic capacity and pediatric antimicrobial stewardship programs is essential in resource-limited settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.4K
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
860
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193